Publication

Romagnolo DF, Donovan MG, Papoutsis AJ, Doetschman TC, Selmin OI. 2017. Genistein Prevents CpG Methylation and Proliferation in Human Breast Cancer Cells with Activated Aromatic Hydrocarbon Receptor. Curr Dev Nutr. 1:e000562. doi:10.3945/cdn.117.000562.

Jim V, LaViolette C, Briehl MM, Ingram JC. 2017. Spatial distribution of uranium in mice kidneys detected by laser ablation inductively coupled plasma mass spectrometry. J Appl Bioanal. 3:43–48. doi:10.17145/jab.17.007.

Aydin I, Villalonga-Planells R, Greune L, Bronnimann MP, Calton CM, Becker M, Lai K-Y, Campos SK, Schmidt MA, Schelhaas M. 2017. A central region in the minor capsid protein of papillomaviruses facilitates viral genome tethering and membrane penetration for mitotic nuclear entry. PLoS Pathog. 13:e1006308. doi:10.1371/journal.ppat.1006308.

Rasmussen LM, Sen N, Vera JC, Liu X, Craig ZR. 2017. Effects of in vitro exposure to dibutyl phthalate, mono-butyl phthalate, and acetyl tributyl citrate on ovarian antral follicle growth and viability. Biol Reprod. 96:1105–1117. doi:10.1095/biolreprod.116.144691.

Kim Y, Huynh JW-Y, Gonzalez VJ. 2017. Evaluation of impact of an external breast shield (FlexiShield) in electronic brachytherapy for breast IORT: A phantom study. Brachytherapy. 16:597–607. doi:10.1016/j.brachy.2017.01.009.

Teye EK, Sido A, Xin P, Finnberg NK, Gokare P, Kawasawa YI, Salzberg AC, Shimko S, Bayerl M, Ehmann WC, et al. 2017. PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features. Oncotarget. 8:29887–29905. doi:10.18632/oncotarget.15136.

Sells E, Pandey R, Chen H, Skovan BA, Cui H, Ignatenko NA. 2017. Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6. Neoplasia. 19:396–411. doi:10.1016/j.neo.2017.02.003.

Padi SKR, Luevano LA, An N, Pandey R, Singh N, Song JH, Aster JC, Yu X-Z, Mehrotra S, Kraft AS. 2017. Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset. Oncotarget. 8:30199–30216. doi:10.18632/oncotarget.16320.

Calton CM, Bronnimann MP, Manson AR, Li S, Chapman JA, Suarez-Berumen M, Williamson TR, Molugu SK, Bernal RA, Campos SK. 2017. Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosis. PLoS Pathog. 13:e1006200. doi:10.1371/journal.ppat.1006200.

Bruce DW, Stefanski HE, Vincent BG, Dant TA, Reisdorf S, Bommiasamy H, Serody DA, Wilson JE, McKinnon KP, Shlomchik WD, et al. 2017. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 127:1813–1825. doi:10.1172/JCI91816.

Cheung MK, Ong SY, Goyal U, Wertheim BC, Hsu CC, Yi SK. 2017. False Positive Positron Emission Tomography / Computed Tomography Scans in Treated Head and Neck Cancers. Cureus. 9:e1146. doi:10.7759/cureus.1146.

Bauman JE, Cohen E, Ferris RL, Adelstein DJ, Brizel DM, Ridge JA, O’Sullivan B, Burtness BA, Butterfield LH, Carson WE, et al. 2017. Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer. 123:1259–1271. doi:10.1002/cncr.30449.

Gonzalez VJ, Hullett CR, Burt L, Rassiah-Szegedi P, Sarkar V, Tward JD, Hazard LJ, Huang YJ, Salter BJ, Gaffney DK. 2017. Impact of prone versus supine positioning on small bowel dose with pelvic intensity modulated radiation therapy. Adv Radiat Oncol. 2:235–243. doi:10.1016/j.adro.2017.01.005.

Rogers JE, Bolonesi RM, Rashid A, Elsayes KM, Elbanan MG, Law L, Kaseb A, Shroff RT. 2017. Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy. J Gastrointest Oncol. 8:347–351. doi:10.21037/jgo.2017.03.03.

Patel S, Demanes DJ, Ragab O, Zhang M, Veruttipong D, Nguyen K, Park S-J, Marks L, Pantuck A, Steinberg M, et al. 2017. High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer. Brachytherapy. 16:299–305. doi:10.1016/j.brachy.2016.11.002.

Bauman JE, Duvvuri U, Gooding WE, Rath TJ, Gross ND, Song J, Jimeno A, Yarbrough WG, Johnson FM, Wang L, et al. 2017. Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer. JCI Insight. 2:e90449. doi:10.1172/jci.insight.90449.

Choy MS, Li Y, Machado LESF, Kunze MBA, Connors CR, Wei X, Lindorff-Larsen K, Page R, Peti W. 2017. Conformational Rigidity and Protein Dynamics at Distinct Timescales Regulate PTP1B Activity and Allostery. Mol Cell. 65:644–658.e5. doi:10.1016/j.molcel.2017.01.014.

Dai J, Miller MA, Everetts NJ, Wang X, Li P, Li Y, Xu J-H, Yao G. 2017. Elimination of quiescent slow-cycling cells via reducing quiescence depth by natural compounds purified from Ganoderma lucidum. Oncotarget. 8:13770–13781. doi:10.18632/oncotarget.14634.

Liu G, Pei F, Yang F, Li L, Amin AD, Liu S, Buchan JR, Cho WC. 2017. Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer. Int J Mol Sci. 18. doi:10.3390/ijms18020367.

Gonzalez VJ, Howell K. 2017. 8 Gy single-fraction radiation for bone metastases: Do the data support a 1-size-fits-all approach?. Pract Radiat Oncol. 7:16–18. doi:10.1016/j.prro.2016.08.012.

Wang M, Nagle RB, Knudsen BS, Rogers GC, Cress AE. 2017. A basal cell defect promotes budding of prostatic intraepithelial neoplasia. J Cell Sci. 130:104–110. doi:10.1242/jcs.188177.

Puvvada SD, Guillén-Rodríguez JM, Rivera XI, Heard K, Inclan L, Schmelz M, Schatz JH, Persky DO. 2017. A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma. Oncology. 93:401–405. doi:10.1159/000479230.

Justiniano R, Perer J, Hua A, Fazel M, Krajisnik A, Cabello CM, Wondrak GT. 2017. A Topical Zinc Ionophore Blocks Tumorigenic Progression in UV-exposed SKH-1 High-risk Mouse Skin. Photochem Photobiol. 93:1472–1482. doi:10.1111/php.12794.

Kendrick S, Rimsza LM, Scott DW, Slack GW, Farinha P, Tan KL, Persky D, Puvvada S, Connors JM, Sehn L, et al. 2017. Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma. Virchows Arch. 470:113–117. doi:10.1007/s00428-016-2041-7.

Oliver KE, Brady WE, Birrer M, Gershenson DM, Fleming G, Copeland LJ, Tewari K, Argenta PA, Mannel RS, Secord AA, et al. 2017. An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience. Gynecol Oncol. 147:243–249. doi:10.1016/j.ygyno.2017.08.004.